WO2003066832A3 - Generation of new insulin cells from progenitor cells present in adult pancreatic islets - Google Patents

Generation of new insulin cells from progenitor cells present in adult pancreatic islets Download PDF

Info

Publication number
WO2003066832A3
WO2003066832A3 PCT/US2003/003859 US0303859W WO03066832A3 WO 2003066832 A3 WO2003066832 A3 WO 2003066832A3 US 0303859 W US0303859 W US 0303859W WO 03066832 A3 WO03066832 A3 WO 03066832A3
Authority
WO
WIPO (PCT)
Prior art keywords
insulin
producing cells
generation
cells
pancreatic islets
Prior art date
Application number
PCT/US2003/003859
Other languages
French (fr)
Other versions
WO2003066832A2 (en
Inventor
Teitelman Gladys
Original Assignee
Univ New York State Res Found
Teitelman Gladys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Teitelman Gladys filed Critical Univ New York State Res Found
Priority to AU2003217357A priority Critical patent/AU2003217357A1/en
Publication of WO2003066832A2 publication Critical patent/WO2003066832A2/en
Publication of WO2003066832A3 publication Critical patent/WO2003066832A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Abstract

The present invention is directed to an in vitro method for converting non­insulin producing cells to insulin-producing cells. A continuous source of insulin-­producing cells is obtained. Insulin from these insulin-producing cells may be collected and administered to a mammal, or the insulin-producing cells may themselves be transplanted into a mammal. Also provided are insulin-producing cells made by the methods of the invention, methods for culturing insulin-producing cells, and methods for treating diabetes with the insulin-producing cells.
PCT/US2003/003859 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets WO2003066832A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003217357A AU2003217357A1 (en) 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35571502P 2002-02-07 2002-02-07
US60/355,715 2002-02-07

Publications (2)

Publication Number Publication Date
WO2003066832A2 WO2003066832A2 (en) 2003-08-14
WO2003066832A3 true WO2003066832A3 (en) 2003-12-24

Family

ID=27734554

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/003859 WO2003066832A2 (en) 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Country Status (2)

Country Link
AU (1) AU2003217357A1 (en)
WO (1) WO2003066832A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9234172B2 (en) 2003-06-27 2016-01-12 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
US9498501B2 (en) 2003-06-27 2016-11-22 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
CA2589063C (en) 2004-12-23 2016-08-09 Ethicon Incorporated Treatment of parkinson's disease and related disorders using postpartum derived cells
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
AU2009327384B2 (en) 2008-12-19 2014-07-10 DePuy Synthes Products, LLC Treatment of lung and pulmonary diseases and disorders
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
EP2411504B1 (en) 2009-03-26 2017-05-10 DePuy Synthes Products, Inc. Human umbilical cord tissue cells as therapy for alzheimer's disease
US9611513B2 (en) 2011-12-23 2017-04-04 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue derived cells

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6020200A (en) * 1995-03-03 2000-02-01 Metabolex, Inc. Encapsulation compositions and methods
US6149907A (en) * 1994-04-13 2000-11-21 Research Corporation Technologies, Inc. Treatments using sertoli cells

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6149907A (en) * 1994-04-13 2000-11-21 Research Corporation Technologies, Inc. Treatments using sertoli cells
US6020200A (en) * 1995-03-03 2000-02-01 Metabolex, Inc. Encapsulation compositions and methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EIZIRIK ET AL.: "Exposure of pancreatic islets to different alkylating agents decreases mitochondrial DNA content but only streptozotocin induced long-lasting functional impairment of beta-cells", BIOCHEMICAL PHARMACOLOGY, vol. 42, no. 12, 1991, pages 2275 - 2282, XP002967912 *
FISHER ET AL.: "Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase and a metal chelator", DIABETES, vol. 29, March 1980 (1980-03-01), pages 213 - 216, XP002967914 *
SUAREZ-PINZON ET AL.: "An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitric prevents diabetes development in NOD mice", JOURNAL OF AUTOIMMUNITY, vol. 16, 2001, pages 449 - 455, XP002967913 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9234172B2 (en) 2003-06-27 2016-01-12 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
US9498501B2 (en) 2003-06-27 2016-11-22 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9585918B2 (en) 2005-12-28 2017-03-07 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells

Also Published As

Publication number Publication date
AU2003217357A8 (en) 2003-09-02
WO2003066832A2 (en) 2003-08-14
AU2003217357A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
SG170068A1 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
WO2003066832A3 (en) Generation of new insulin cells from progenitor cells present in adult pancreatic islets
WO2004050827A3 (en) Cultured human pancreatic islets, and uses thereof
AR111785A2 (en) IN VITRO METHOD OF PRODUCTION OF Erythrocytes
SG152273A1 (en) Pdx1 expressing endoderm
SG149061A1 (en) Definitive endoderm
WO2008013664A3 (en) Methods of producing pancreatic hormones
WO2001023528A8 (en) Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
DE60026142D1 (en) PROCESS FOR THE PREPARATION OF OLIGOSACCHARIDE
UA91322C2 (en) Method for the production of three-dimensional fiber construction, fiber construction (variants), method for the production of detail and the detail therein (variants)
ATE260971T1 (en) METHOD FOR THE IN VITRO CULTIVATION OF DENDRITIC PRECURSOR CELLS AND THEIR USE FOR IMMUNOGENIC PRODUCTION
ES2166316B1 (en) PROCEDURE FOR THE PRODUCTION OF ETHANOL FROM LIGNOCELLULOSIC BIOMASS USING A NEW THERMOTOLERING YEAST.
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
WO2003043486A3 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
WO2002078449A3 (en) Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
BR0311362A (en) methods, compositions and growth and differentiation factors for producing insulin producing cells
ATE467420T1 (en) METHOD OF USING GUAVA EXTRACT AND COMPOSITION WITH GUAVA EXTRACT
WO2006108882A8 (en) In vitro production of a cell population using feeder cells
MX2009004776A (en) Bone marrow-derived mesenchymal stem cells as a source of neural progenitors.
MY161723A (en) Generation of chemical building blocks from plant biomass by selective depolymerization
AR048559A1 (en) CARBON BLACK AND MULTIPLE STAGES PROCESS TO PREPARE IT
MX2009007640A (en) Accelerated method for converting carbon dioxide into energy.
ATE481477T1 (en) ENDOTHELIAL PRODUCER CELLS AND METHODS OF USE THEREOF
Sambathkumar et al. Pluripotent stem cell-derived pancreatic progenitors and β-like cells for type 1 diabetes treatment
MX2021014681A (en) Sox9-induced oligodendrocyte progenitor cells.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP